跳至主要内容
临床试验/NCT01501422
NCT01501422已完成3 期

Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women at Menopause Clinic, King Chulalongkorn Memorial Hospital, Double- Blind, Randomized, Placebo-controlled Trial

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Sleep efficiency (SE)

研究概览

简要总结

  1. Sex hormone including estrogen have synergistic effect to serotonin activity and decrease activity of monoamine oxidase activity so the norepinephrine is not be metabolized, these substance are important to regulate hemostasis and circadian process of sleep
  2. Estrogen also regulate gamma-aminobutyric acid (GABA) secretion
  • GABA substance is in order to initiate sleep and continue sleep
  1. According to epidemiologic data, problem of sleep was increasing in postmenopause group compare to premenopause group (aged-match)
  2. This research perform to find out the actual effect of estrogen in improving sleep quality.

详细描述

  1. 40-60 year-old postmenopausal women with insomnia and mild-moderate vasomotor symptom were screened and included in project
  2. Block of four randomization was use to categorize participants into 2 groups
  • Study group (estrogen patch)
  • Control group (placebo patch)
  1. Sleep quality was measured before intervention by subjective and objective sleep quality
  • Subjective sleep quality (self sleep questionnaire)
  • Objective sleep quality (wrist actigraphy and sleep diary):

wrist actigraph sleep test at home for 1 week 4. Intervention phase : continuous use of weekly patch for 8 weeks

  • Estrogen patch in study group
  • Placebo patch in control group
  1. Follow up phase

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women 40-60 years old
  • Mild to moderate vasomotor symptom
  • fluent read and write in Thai language
  • Inform consent

排除标准

  • Acute liver and gall bladder disease
  • undiagnosed abnormal bleeding per vagina
  • History of BIRADs 3 from mammogram
  • History or current venous thrombosis, embolism
  • diagnosis of sleep disorder
  • use of hypnotic drug or antihistamine in the past month
  • Diagnosis of psychiatric disorder such as depressive disorder, schizophrenia, anxiety disorder
  • No past history of malignancy
  • No history of chronic renal disease, alzheimer's disease, uncontrolled hypertension, uncontrolled diabetes mellitus
  • history of estrogen use in past 6 months
  • drug abuse, Alcohol

研究组 & 干预措施

Estrogen

Experimental

Use estrogen patch for 8 weeks

干预措施: Estrogen patch (Drug)

Placebo

Experimental

Use placebo patch for 8 weeks

干预措施: Placebo (Drug)

结局指标

主要结局

Sleep efficiency (SE)

时间窗: 8 months

Sleep efficiency is proportion of sleep in the period potentially filled by sleep-ratio of total sleep time to time in bed.

次要结局

  • Sleep latency (SL)(8 months)
  • Total sleep time (TST)(8 months)
  • Number of awakening(8 months)
  • Score of two sleep quality assessment questionnaires.(8 months)
  • Wake time after sleep onset (WASO)(8 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pimpika Tansupswatdikul, MD.

Principle investigator

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验